Reduces Chronic Inflammation: May lower systemic inflammation, a key driver of aging and age-related disease
Kaynak M, Meuffels DE
Freitas, Victor De
Theres also a feedback-loop problem
CHST14 EDS/musculocontractural EDS The features of this rare condition (MIM 601776) include progressive kyphoscoliosis, adducted thumbs in infancy, clubfoot, arachnodactyly, joint hypermobility, fragile and hyperextensible skin with atrophic scars and delayed wound healing.20 22 Arthrochalasic EDS Arthrochalasic EDS (MIM 130060) is extremely rare.23 Congenital bilateral hip dislocation, severe joint hypermobility with recurrent dislocations, skin hyperextensibility, easy bruising, atrophic scars, kyphoscoliosis and osteopaenia are the features of this autosomal-dominant condition
BPC-157 has not been proven safe or effective for any condition and is not eligible for inclusion on the 503B Bulks List for compounding. FDA Review Memorandum, 2023 In other words, BPC157 does not meet FDA standards for legal use in clinical practice
